Related Experiment Video
Updated: Mar 17, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Successful Treatment of Peritoneal Dialysis-related Peritonitis due to Mycobacterium iranicum
Koji Inagaki1, Makoto Mizutani, Yasuko Nagahara
1Department of Nephrology, Handa City Hospital, Japan.
Abstract:
A 68-year-old man on peritoneal dialysis (PD) was hospitalized with the clinical picture of peritonitis. The patient was diagnosed with peritonitis caused by nontuberculous mycobacteria (NTM) according to positive Ziehl-Neelsen staining and negative Mycobacterium tuberculosis polymerase chain reaction results. Oral levofloxacin and clarithromycin, and later intraperitoneal imipenem were started. According to the anti-NTM susceptibility test results, oral minocycline was administered. The patient was treated for 6 months. He recovered without PD catheter removal; thus, PD was successfully continued. A genetic analysis identified the isolate as Mycobacterium iranicum. This is the first report of PD-related peritonitis caused by M. iranicum.
Insights
Peritonitis in peritoneal dialysis (PD) patients can be caused by nontuberculous mycobacteria (NTM). This case highlights successful treatment of Mycobacterium iranicum peritonitis without PD catheter removal.
Area of Science:
- Microbiology
- Nephrology
- Infectious Diseases
Background:
- Peritonitis is a serious complication for patients undergoing peritoneal dialysis (PD).
- Nontuberculous mycobacteria (NTM) are an uncommon but significant cause of PD-related peritonitis.
- Early and accurate diagnosis is crucial for effective management.
Observation:
- A 68-year-old male PD patient presented with symptoms of peritonitis.
- Ziehl-Neelsen staining was positive for acid-fast bacilli, while Mycobacterium tuberculosis PCR was negative.
- Genetic analysis identified the causative agent as Mycobacterium iranicum.
Findings:
- The patient received a combination of oral and intraperitoneal antibiotics, including levofloxacin, clarithromycin, imipenem, and minocycline based on susceptibility testing.
- Treatment lasted for 6 months.
- The patient recovered from peritonitis, and PD therapy was successfully continued without the need for catheter removal.
Implications:
- This case represents the first reported instance of PD-related peritonitis caused by Mycobacterium iranicum.
- Successful management of NTM peritonitis with oral and intraperitoneal antibiotics is possible, preserving the PD catheter.
- Highlights the importance of considering NTM in the differential diagnosis of peritonitis in PD patients and guiding therapy with susceptibility testing.
More Related Videos
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

